BGB-433

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameBGB-433
Drug Alias Namedual PARP 1/2/3 and tankyrase 1/2 inhibitor (Beigene)BGB-433
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTankyrase-2 inhibitorsPoly (ADP-Ribose) Polymerase 2 inhibitorsTankyrase-1 inhibitors +[5] 
TargetsTankyrase-1Tankyrase-2Poly (ADP-Ribose) Polymerase 3 +[5] 
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesBeOne Medicines (Beijing) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBeOne Medicines (Beijing) Co Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A